Revvity Inc
(NYSE:RVTY)
$
125.96
1.14 (0.91%)
Market Cap: 15.54 Bil
Enterprise Value: 17.48 Bil
PE Ratio: 91.47
PB Ratio: 1.97
GF Score: 82/100 
Revvity Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 12, 2023 / 01:40PM GMT
Release Date Price:
$109.17
(+1.37%)
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
There we go. I'm Catherine Schulte. I cover life sciences and diagnostics here at Baird. Very excited to have Revvity presenting today. From the company, we have the CEO, Prahlad Singh. And I think we are going to dive right into Q&A. But if you have a question, you can e-mail it to [email protected], and I will pass it along. So Prahlad, thanks so much for joining us.
Prahlad R. Singh
Revvity, Inc. - CEO, President & Director
Nice to be here, Catherine, this evening.
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
You as well.
Questions & Answers
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
May be just starting off, you just completed your full quarter as Revvity. Maybe just talk through how
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers